These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18053120)

  • 21. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome.
    Leal-Cerro A; Povedano J; Astorga R; Gonzalez M; Silva H; Garcia-Pesquera F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3378-81. PubMed ID: 10487713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency.
    van Bunderen CC; Deijen JB; Drent ML
    Health Qual Life Outcomes; 2018 Jul; 16(1):135. PubMed ID: 29980224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study.
    Pekarovics S; Beres A; Kelly C; Billes SK; Heaton AL
    Front Endocrinol (Lausanne); 2023; 14():1053692. PubMed ID: 36998474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the underlying etiology of growth hormone deficiency on serum IGF-I SDS levels during GH treatment in children.
    Léger J; Mohamed D; Dos Santos S; Ben Azoun M; Zénaty D; Simon D; Paulsen A; Martinerie L; Chevenne D; Alberti C; Carel JC; Guilmin-Crepon S
    Eur J Endocrinol; 2017 Sep; 177(3):267-276. PubMed ID: 28760908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia.
    McCall-Hosenfeld JS; Goldenberg DL; Hurwitz S; Adler GK
    J Rheumatol; 2003 Apr; 30(4):809-14. PubMed ID: 12672204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
    Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.
    Johansson JO; Wirén L; Oscarsson J; Bengtsson BA; Johannsson G
    Growth Horm IGF Res; 2003 Dec; 13(6):306-15. PubMed ID: 14624763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.
    Rasmussen MH; Janukonyté J; Klose M; Marina D; Tanvig M; Nielsen LF; Höybye C; Andersen M; Feldt-Rasmussen U; Christiansen JS
    J Clin Endocrinol Metab; 2016 Mar; 101(3):988-98. PubMed ID: 26727076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency.
    Chihara K; Koledova E; Shimatsu A; Kato Y; Kohno H; Tanaka T; Teramoto A; Bates PC; Attanasio AF
    Eur J Endocrinol; 2005 Jul; 153(1):57-65. PubMed ID: 15994746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.
    Murray RD; Wieringa GE; Lissett CA; Darzy KH; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):525-32. PubMed ID: 11966746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel.
    Caron P; Bex M; Cullen DR; Feldt-Rasmussen U; Pico Alfonso AM; Pynka S; Racz K; Schopohl J; Tabarin A; Valimaki MJ;
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):734-40. PubMed ID: 15163338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome.
    Denko CW; Malemud CJ
    Rheumatol Int; 2005 Mar; 25(2):146-51. PubMed ID: 15759159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone perturbations in fibromyalgia: a review.
    Jones KD; Deodhar P; Lorentzen A; Bennett RM; Deodhar AA
    Semin Arthritis Rheum; 2007 Jun; 36(6):357-79. PubMed ID: 17224178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.